Microbot Medical (MBOT) Stock: Buy, Sell, or Hold?
MBOT - Microbot Medical, Inc. Common Stock
$0.94
0.00 (0.19%)
▲
5d:
-0.85%
30d:
-28.1%
90d:
-44.92%
HOLD
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 11, 2026
18d
Get Alerted When MBOT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MBOT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: MBOT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: MBOT is currently trading at $0.94, which is considered oversold relative to its 30-day fair value range of $1.02 to $1.37. From a valuation perspective, the stock is trading at a discount (Forward PE: -3.1) compared to its historical average (18.5). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MBOT is in a strong downtrend. The price is currently testing key support at $0.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MBOT scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.33 (+572.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MBOT is in a strong downtrend. The price is currently testing key support at $0.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MBOT scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.33 (+572.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.02 -
$1.37
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
95.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 572.4% below Wall St target ($6.33)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Bottoming setup, but lagging the sector by 15% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$1.02 -
$1.37
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.93
Resistance Level
$1.09
Current Trend
Strong Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.07
Wall Street Target
$6.33
(+572.4%)
PE vs Historical
-3.1 vs 18.5
CHEAP
Share & Embed Analysis
Last updated: October 22, 2026 7:56 PM ET
Data refreshes hourly during market hours. Next update: 8:56 PM
Data refreshes hourly during market hours. Next update: 8:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MBOT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 44 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 73 BUY |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
15 analysts |
$171 | 48 HOLD |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$167 | 34 SELL |
